tirzepatide psychiatric side effects The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy tirzepatide vs semaglutide side effects

23 Animal studies have demonstrated neuroprotective effects associated with GLP-1RA use in Alzheimer and Parkinson disease, stroke, and ocular hypertension

When GLP-1 medication, a GLP-1 receptor agonist, binds to these receptors, it triggers a cascade of events that ultimately leads to appetite suppression

Always consult your healthcare provider before making any changes to your medication

Early water retention, hormonal shifts, or increased calorie intake can temporarily mask fat loss

While causation cannot yet be established, vitamin D status may serve as a biomarker of metabolic response to semaglutide

A good medication deserves a good framework